CORRELATES OF HIV IMMUNE PROTECTION LABORATORY NIH GUIDE, Volume 22, Number 25, July 16, 1993 RFP AVAILABLE: NIAID-DAIDS-94-12 P.T. Keywords: National Institute of Allergy and Infectious Diseases The National Institute of Allergy and Infectious Diseases (NIAID), NIH has a requirement for a Correlates of HIV Immune Protection Laboratory that will provide extensive, coordinated, in-depth evaluation of the immunology and/or virology of recipients of acquired immunodeficiency syndrome (AIDS) vaccine(s) who are not protected against HIV-1. Vaccinees or subjects in natural history cohorts who are apparently exposed to, but not infected by, HIV and when available, their infected partners, also will be included in these extensive evaluation studies. Control subjects will include infected placebo recipients and uninfected vaccine responders who may have been exposed to HIV during the same or parallel vaccine studies, recent seroconverters, and HIV-infected subjects with evidence of prolonged asymptomatic periods following infection who have been identified in natural history cohorts. Therefore, this proposed Contract will establish the Correlates of HIV Immune Protection Laboratory, which will provide extensive, in-depth evaluation of the humoral and cellular immune responses of vaccinee and cohort study subjects and controls. In addition, from infected subjects, this laboratory will isolate and characterize the genotype and both the serological and biological phenotype of infecting HIV. This contract is intended to support the NIAID mission of development and clinical testing of AIDS vaccines. It is anticipated that a single contract will be awarded to carry out highly coordinated immunological, virological, and molecular biological assessments. It is further anticipated that a consortium of laboratories with the distinct expertise will be required for the successful completion of the different technical tasks. This is an announcement for an anticipated Request for Proposals (RFP). The issuance of RFP No. NIH-NIAID-DAIDS-94-12 will be on or about August 15, 1993 and proposals will be due by the close of business on November 15, 1993. It is anticipated that one contract will be awarded to carry out highly coordinated immunological, virological, and molecular virological assessments as a result of this solicitation. It is expected that the contract will have a five-year period of performance and a completion type cost- reimbursement contract is anticipated. INQUIRIES Requests for the RFP are to be directed in writing to: Mr. Lawrence Butler Contract Management Branch National Institute of Allergy and Infectious Diseases Solar Building, Room 3C07 6003 Executive Boulevard Bethesda, MD 20892 (use Rockville, Maryland 20852 for overnight mail service) Please provide this office with three self-addressed mailing labels. Telephone inquiries will not be honored and all inquiries must be in writing. A short-form version of the RFP will be provided, which includes the Statement of Work and the Evaluation Criteria to be used for selection of the awardee. All proposals from responsible sources will be considered by the NIAID. This advertisement does not commit the Government to award a contract. No collect calls will be accepted. .
Return to NIH Guide Main Index
Office of Extramural Research (OER) |
National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892 |
Department of Health and Human Services (HHS) |
||||||||
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files. |